Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision-Reference-Cited by-同舟云学术

Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision

Published:2023-06-11 Issue:3 Volume:114 Page:507-510
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Burton Jackson¹,Abuasal Bilal²^ORCID,Bachhav Sagar³,Connarn Jamie⁴,Cosman Josh⁵,Gupta Neeraj⁶^ORCID,Jing Jing⁷,Kim Sarah⁸^ORCID,Long Tao⁶,Terranova Nadia⁹^ORCID,Venkatakrishnan Karthik¹⁰,Wang Jian¹¹,Liu Qi²^ORCID

Affiliation:

1. Clinical Pharmacology and Pharmacometrics Biogen Inc. Cambridge Massachusetts USA

2. Office of Clinical Pharmacology, Office of Translational Sciences CDER, FDA Silver Spring Maryland USA

3. Clinical Pharmacology AbbVie Inc. North Chicago Illinois USA

4. Clinical Pharmacology, Modeling and Simulation Amgen Inc. South San Francisco California USA

5. Digital Sciences Abbvie, Inc. North Chicago Illinois USA

6. Quantitative Clinical Pharmacology Takeda Development Center Americas, Inc. (TDCA) Lexington Massachusetts USA

7. Clinical Pharmacology Genentech, Inc. South San Francisco California USA

8. Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida Orlando Florida USA

9. Merck Institute for Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA Darmstadt Germany

10. EMD Serono Research and Development Institute, Inc. Billerica Massachusetts USA

11. Oncology Regulatory Science Strategy & Excellence AstraZeneca Wilmington Delaware USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2955

Reference10 articles.

1. A Modeling Framework to Characterize Cytokine Release upon T‐Cell–Engaging Bispecific Antibody Treatment: Methodology and Opportunities

2. Advances in oligonucleotide drug delivery

3. A semi automated pipeline to capture real world tumor dynamics from routine PET/CT images;Abler D.;JCO Clin. Cancer Inform.,2023

4. Imaging biomarkers in neurodegeneration: current and future practices

5. MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Therapeutic Modalities: The Future is Now;Clinical Pharmacology & Therapeutics;2023-08-18